Detection of Influenza or SARS-CoV-2 Infection by IMS of Nasal Air Sampling

NCT04282135 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 76

Last updated 2020-07-14

No results posted yet for this study

Summary

Multicapillary Ion mobility spectrometry of nasal air aspirates shall be investigated as screening tool for the detection of Influenza and SARS-CoV-2- infection.

Conditions

Interventions

DIAGNOSTIC_TEST

MCC IMS

Diagnosis by MCC IMS

Sponsors & Collaborators

  • Klinikum Bayreuth GmbH

    lead INDUSTRY

Principal Investigators

  • Claus Steppert, MD · Klinikum Bayreuth, Dpt. Pulmonology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-15
Primary Completion
2020-05-08
Completion
2020-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04282135 on ClinicalTrials.gov